𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Survival and prognostic factors of women with advanced ovarian cancer and complete response after a carboplatin–paclitaxel chemotherapy

✍ Scribed by Gianpiero Polverino; Fabio Parazzini; Giovanna Stellato; Giovanna Scarfone; Sonia Cipriani; Giorgio Bolis

Book ID
113960008
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
87 KB
Volume
99
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Continued chemotherapy after complete re
Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer : A meta-analysis
✍ Lisa M. Hess; Nan Rong; Patrick O. Monahan; Paridha Gupta; Champ Thomaskutty; Da 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

## Abstract ## BACKGROUND. Ovarian cancer (OC) is associated with a >75% risk of recurrence after completion of primary therapy. Several clinical trials have explored the role of continued therapy after complete response to primary adjuvant therapy to reduce the risk of recurrence; however, these

Survival of women with advanced ovarian
Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy
✍ Giorgio Bolis; Antonella Villa; Paolo Guarnerio; Cristina Ferraris; Nicoletta Ga 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB

The purpose of the study was to analyze the determinants of long term survival in women with advanced ovarian cancer and negative second-look laparotomy. ## METHODS. A series of 140 advanced (Stage III-rv) ovarian cancer patients (median age, 54 years; range, 22-74 years) with negative second-look